Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Centrosome amplification arises before neoplasia and increases upon p53 loss in tumorigenesis.

Lopes CAM, Mesquita M, Cunha AI, Cardoso J, Carapeta S, Laranjeira C, Pinto AE, Pereira-Leal JB, Dias-Pereira A, Bettencourt-Dias M, Chaves P.

J Cell Biol. 2018 Jul 2;217(7):2353-2363. doi: 10.1083/jcb.201711191. Epub 2018 May 8.

2.

Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas.

Marques IJ, Moura MM, Cabrera R, Pinto AE, Simões-Pereira J, Santos C, Menezes FD, Montezuma D, Henrique R, Rodrigues Teixeira M, Leite V, Cavaco BM.

Clin Endocrinol (Oxf). 2017 Oct;87(4):394-399. doi: 10.1111/cen.13375. Epub 2017 Jun 19.

PMID:
28502101
3.

Prognostic relevance of DNA flow cytometry in breast cancer revisited: The 25-year experience of the Portuguese Institute of Oncology of Lisbon.

Pinto AE, Pereira T, Silva GL, André S.

Oncol Lett. 2017 Apr;13(4):2027-2033. doi: 10.3892/ol.2017.5718. Epub 2017 Feb 13.

4.

Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.

Pinto AE, Pereira T, Silva GL, André S.

Breast. 2015 Aug;24(4):449-55. doi: 10.1016/j.breast.2015.04.004. Epub 2015 Apr 25.

PMID:
25920680
5.

Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).

Pereira JS, da Silva JG, Tomaz RA, Pinto AE, Bugalho MJ, Leite V, Cavaco BM.

Endocrine. 2015 May;49(1):204-14. doi: 10.1007/s12020-014-0470-0. Epub 2014 Nov 9.

PMID:
25381600
6.

Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype.

Rito M, Schmitt F, Pinto AE, André S.

Virchows Arch. 2014 Aug;465(2):185-91. doi: 10.1007/s00428-014-1603-9. Epub 2014 Jun 6.

PMID:
24903673
7.

Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical/prognostic behaviour.

Pinto AE, Silva GL, Henrique R, Menezes FD, Teixeira MR, Leite V, Cavaco BM.

Eur J Endocrinol. 2013 Dec 21;170(2):321-7. doi: 10.1530/EJE-13-0865. Print 2014 Feb.

PMID:
24272198
8.

Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer.

Pinto AE, Areia F, Pereira T, Cardoso P, Aparício M, Silva GL, Ferreira MC, André S.

Springerplus. 2013 Aug 9;2:375. doi: 10.1186/2193-1801-2-375. eCollection 2013.

9.

[DNA ploidy is an independent prognostic biomarker in breast invasive ductal carcinoma].

Pinto AE, Pereira T, Silva GL, Ferreira MC, André S.

Acta Med Port. 2012 Nov-Dec;25(6):399-407. Epub 2013 Jan 28. Portuguese.

10.

DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.

Pinto AE, Pereira T, Santos M, Branco M, Dias A, Silva GL, Ferreira MC, André S.

Ann Surg Oncol. 2013 May;20(5):1530-7. doi: 10.1245/s10434-012-2804-6. Epub 2012 Dec 20.

PMID:
23250736
11.

S-phase fraction and ploidy as predictive markers in primary disease and recurrence of papillary thyroid carcinoma.

Pinto AE, Silva GL, Pereira T, Cabrera RA, Santos JR, Leite V.

Clin Endocrinol (Oxf). 2012 Aug;77(2):302-9. doi: 10.1111/j.1365-2265.2012.04363.x.

PMID:
22329804
12.

Ploidy and S-phase fraction as predictive markers of response to radiotherapy in cervical cancer.

Pinto AE, Pires A, Silva G, Bicho C, André S, Soares J.

Pathol Res Pract. 2011 Oct 15;207(10):623-7. doi: 10.1016/j.prp.2011.07.007. Epub 2011 Sep 21.

PMID:
21940107
13.

High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas.

Moura MM, Cavaco BM, Pinto AE, Leite V.

J Clin Endocrinol Metab. 2011 May;96(5):E863-8. doi: 10.1210/jc.2010-1921. Epub 2011 Feb 16.

PMID:
21325462
14.

Clinical implications of molecular markers in follicular cell-derived thyroid cancer.

Pinto AE, Leite V, Soares J.

Expert Rev Mol Diagn. 2009 Oct;9(7):679-94. doi: 10.1586/erm.09.54. Review.

PMID:
19817553
15.

BCL-6 oncoprotein in breast cancer: loss of expression in disease progression.

Pinto AE, André S, Silva G, Vieira S, Santos AC, Dias S, Soares J.

Pathobiology. 2009;76(5):235-42. doi: 10.1159/000228899. Epub 2009 Oct 2.

16.
17.

Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas.

Moura MM, Cavaco BM, Pinto AE, Domingues R, Santos JR, Cid MO, Bugalho MJ, Leite V.

Br J Cancer. 2009 Jun 2;100(11):1777-83. doi: 10.1038/sj.bjc.6605056. Epub 2009 Apr 28.

18.

Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma.

Pinto AE, Silva G, Banito A, Leite V, Soares J.

Oncol Rep. 2008 Oct;20(4):913-9.

PMID:
18813835
19.

Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.

André S, Pinto AE, Laranjeira C, Quaresma M, Soares J.

Pathobiology. 2007;74(6):323-7. Epub 2007 Dec 13.

20.

Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.

Banito A, Pinto AE, Espadinha C, Marques AR, Leite V.

Clin Endocrinol (Oxf). 2007 Nov;67(5):706-11. Epub 2007 Jul 25.

PMID:
17651453
21.

DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.

Pinto AE, André S, Pereira T, Silva G, Soares J.

Pathobiology. 2006;73(2):63-70.

PMID:
16943686
22.
23.

Prognostic biomarkers in renal cell carcinoma: relevance of DNA ploidy in predicting disease-related survival.

Pinto AE, Monteiro P, Silva G, Ayres JV, Soares J.

Int J Biol Markers. 2005 Oct-Dec;20(4):249-56.

PMID:
16398407
24.
25.

[DNA flow cytrometry in solid tumors].

Pinto AE, Fonseca I, Soares J.

Acta Med Port. 2002 Mar-Apr;15(2):133-42. Review. Portuguese.

26.

Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.

Pinto AE, Cabeçadas J, Nóbrega SD, Mendonça E.

Diagn Cytopathol. 2003 Oct;29(4):194-9.

PMID:
14506670
27.

Overall survival in advanced breast cancer: relevance of progesterone receptor expression and DNA ploidy in fine-needle aspirates of 392 patients.

Pinto AE, André S, Mendonça E, Silva G, Soares J.

Int J Biol Markers. 2003 Jan-Mar;18(1):7-12.

PMID:
12699057
28.

Independent prognostic value of hormone receptor expression and S-phase fraction in advanced breast cancer.

Pinto AE, Mendonça E, André S, Nóbrega SD, Soares J.

Anal Quant Cytol Histol. 2002 Dec;24(6):345-54.

PMID:
12508694
29.

Male breast cancer--a reappraisal of clinical and biologic indicators of prognosis.

André S, Fonseca I, Pinto AE, Cardoso P, Pereira T, Soares J.

Acta Oncol. 2001;40(4):472-8.

PMID:
11504306
30.

Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma.

Pinto AE, André S, Pereira T, Nóbrega S, Soares J.

J Clin Pathol. 2001 Jul;54(7):543-9.

31.
32.

Objective biologic parameters and their clinical relevance in assessing salivary gland neoplasms.

Pinto AE, Fonseca I, Martins C, Soares J.

Adv Anat Pathol. 2000 Sep;7(5):294-306. Review.

PMID:
10976908
34.
35.

Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression.

Soares J, Pinto AE, Cunha CV, André S, Barão I, Sousa JM, Cravo M.

Cancer. 1999 Jan 1;85(1):112-8.

PMID:
9921982
36.

Clear cell meningioma variant and clinical aggressiveness.

Pimentel J, Fernandes A, Pinto AE, Fonseca I, Moura Nunes JF, Lobo Antunes J.

Clin Neuropathol. 1998 May-Jun;17(3):141-6.

PMID:
9625306
37.

Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer.

Pinto AE, André S, Nogueira M, Mendonça E, Soares J.

J Clin Pathol. 1997 Jul;50(7):591-5.

38.

Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma.

Pinto AE, Chaves P, Fidalgo P, Oliveira AG, Leitão CN, Soares J.

Dis Colon Rectum. 1997 Apr;40(4):411-9.

PMID:
9106689
39.

Malignant salivary gland neoplasms: a cytogenetic study of 19 cases.

Martins C, Fonseca I, Roque L, Pinto AE, Soares J.

Eur J Cancer B Oral Oncol. 1996 Mar;32B(2):128-32.

PMID:
8736176
40.

Homicidal hanging.

Vieira DN, Pinto AE, Sá FO.

Am J Forensic Med Pathol. 1988 Dec;9(4):287-9. Review.

PMID:
3071133

Supplemental Content

Loading ...
Support Center